SYNTHESIS OF A 4A, 5-EPOXY-5-DEAZAFLAVIN DERIVATIVEVARGO D; JORNS MS.1979; J. AMER. CHEM. SOC.; USA; DA. 1979; VOL. 101; NO 25; PP. 7623-7626; BIBL. 21 REF.Article

FAECAL BACTERIAL FLORA IN CANCER OF THE COLONVARGO D; MOSKOVITZ M; FLOCH MH et al.1980; ; GUT; ISSN 0017-5749; GBR; DA. 1980; VOL. 21; NO 8; PP. 701-705; BIBL. 33 REF.Article

PYRIMIDINE RING CONTRACTION WITH A 5-DEAZAFLAVIN 4A,5-EPOXIDE DERIVATIVE. MODEL STUDIES FOR REACTIONS WITH ENZYME-BOUND EPOXIDE INTERMEDIATESPOKORA A; JORNS MS; VARGO D et al.1982; J. AM. CHEM. SOC.; ISSN 0002-7863; USA; DA. 1982; VOL. 104; NO 20; PP. 5466-5469; BIBL. 15 REF.Article

The Feasibility of and Requirements for Establishing a Comparative Faunal CollectionVARGO, J; VARGO, D.North American archaeologist. 1985, Vol 6, Num 4, pp 283-287, issn 0197-6931Article

Laparoscopic repair of a traumatic ventral herniaVARGO, D; SCHURR, M; HARMS, B et al.The Journal of trauma. 1996, Vol 41, Num 2, pp 353-355, issn 0022-5282Conference Paper

Colonic bacterial flora and serum cholesterol: alterations induced by dietary citrus pectinVARGO, D; DOYLE, R; FLOCH, M. H et al.The American journal of gastroenterology. 1985, Vol 80, Num 5, pp 361-364, issn 0002-9270Article

Free-tissue transfer with the aid of loupe manification : experience with 251 proceduresSHENAQ, S. M; KLEBUC, M. J. A; VARGO, D et al.Plastic and reconstructive surgery (1963). 1995, Vol 95, Num 2, pp 261-269, issn 0032-1052Article

Reaction of enzyme-bound 5-deazaflavin with peroxides: pyrimidine ring contraction via an epoxide intermediateSCHUMAN JORNS, M; BALLENGER, C; KINNEY, G et al.The Journal of biological chemistry (Print). 1983, Vol 258, Num 14, pp 8561-8567, issn 0021-9258Article

The pharmacodynamics of torsemide in patients with congestive heart failureVARGO, D; KRAMER, W. G; BLACK, P. K et al.Clinical pharmacology and therapeutics. 1994, Vol 56, Num 1, pp 48-54, issn 0009-9236Article

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failureVARGO, D. L; KRAMER, W. G; BLACK, P. K et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 6, pp 601-609, issn 0009-9236Article

Comparison of zafirlukast (Accolate®) absorption after oral and colonic administration in humansFISCHER, J. D; SONG, M. H; SUTTLE, A. B et al.Pharmaceutical research. 2000, Vol 17, Num 2, pp 154-159, issn 0724-8741Article

Mechanisms of tolerance induced by an immunotoxin against CD3∈ in a rhesus kidney allograft modelFECHNER, J. H; VARGO, D. J; GEISSLER, E. K et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 1158Conference Paper

FN18-CRM9 immunotoxin promotes tolerance in primate renal allograftsKNECHTLE, S. J; VARGO, D; NEVILLE, D. M et al.Transplantation. 1997, Vol 63, Num 1, pp 1-6, issn 0041-1337Article